More on BMY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Dividends

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BMY Balance Sheet

Click line-items for a historical chart and %
Current Assets:
Cash and cash equivalents 4.85B
Marketable securities 2.37B
Receivables 3.32B
Inventories 1.57B
Deferred income taxes 1.51B
Prepaid expenses and other 482M
Total Current Assets 14.18B
Property, plant and equipment 4.39B
Goodwill 7.05B
Other intangible assets 1.72B
Deferred income taxes 1.02B
Marketable securities 4.33B
Other assets 779M
Total Assets 33.45B
Current Liabilities:
Short-term borrowings 401M
Accounts payable 2.57B
Accrued expenses 2.29B
Deferred income 995M
Accrued rebates and returns 914M
U.S. and foreign income taxes payable 312M
Dividends payable 623M
Total Current Liabilities 8.1B
Pension, postretirement, and postemployment liabilities 806M
Deferred income 810M
U.S. and foreign income taxes payable 552M
Other liabilities 618M
Long-term debt 7.27B
Total Liabilities 18.25B
Commitments and contingencies (Note 14) 0
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of $50 per share 0
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2011 and 2010 221M
Capital in excess of par value of stock 1.5B
Accumulated other comprehensive loss -2.61B
Retained earnings 33.15B
Less cost of treasury stock - 500 million common shares in 2011 and 501 million in 2010 -17.12B
Total Bristol-Myers Squibb Company Shareholders' Equity 15.14B
Noncontrolling interest 58M
Total Equity 15.2B
Total Liabilities and Equity 33.45B